Connexin 26 anomaly
Connexin 26 anomaly is a genetic disorder that affects the protein Connexin 26, which is encoded by the GJB2 gene. This anomaly is associated with a variety of hearing loss conditions, including both syndromic and non-syndromic forms.
Overview[edit | edit source]
Connexin proteins, such as Connexin 26, are crucial for the formation of gap junctions, which are channels that allow for direct communication between the cytoplasm of adjacent cells. These proteins are particularly important in the inner ear, where they facilitate the passage of potassium ions necessary for the conversion of sound into electrical signals.
In the case of a Connexin 26 anomaly, mutations in the GJB2 gene lead to the production of a faulty Connexin 26 protein. This can disrupt the formation of gap junctions and impair the function of the inner ear, leading to hearing loss.
Types of Hearing Loss Associated with Connexin 26 Anomaly[edit | edit source]
There are several types of hearing loss associated with Connexin 26 anomaly:
- Non-syndromic hearing loss: This is the most common type of hearing loss associated with Connexin 26 anomaly. It is characterized by hearing loss that is not associated with any other symptoms or medical conditions.
- Syndromic hearing loss: In some cases, Connexin 26 anomaly can lead to hearing loss that is part of a syndrome, meaning it is accompanied by other symptoms or medical conditions. Examples of syndromes associated with Connexin 26 anomaly include Keratitis-Ichthyosis-Deafness syndrome and Hystrix-like ichthyosis-deafness syndrome.
Diagnosis and Treatment[edit | edit source]
Diagnosis of Connexin 26 anomaly typically involves genetic testing to identify mutations in the GJB2 gene. Treatment options are currently limited and primarily involve management of symptoms. This can include the use of hearing aids or cochlear implants to improve hearing.
Research[edit | edit source]
Research into Connexin 26 anomaly is ongoing, with scientists seeking to better understand the role of Connexin 26 in the inner ear and to develop new treatments for hearing loss associated with this condition.
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD